Onkure Therapeutics, Stock Current Valuation
| OKUR Stock | 15.42 0.66 4.47% |
Valuation analysis of OnKure Therapeutics, helps investors to measure OnKure Therapeutics,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of 12/02/2024, Cash is likely to drop to about 22.8 M.
Overvalued
Today
Please note that OnKure Therapeutics,'s price fluctuation is somewhat reliable at this time. Calculation of the real value of OnKure Therapeutics, is based on 3 months time horizon. Increasing OnKure Therapeutics,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the OnKure stock is determined by what a typical buyer is willing to pay for full or partial control of OnKure Therapeutics,. Since OnKure Therapeutics, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OnKure Stock. However, OnKure Therapeutics,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.42 | Real 13.28 | Hype 15.51 | Naive 14.21 |
The intrinsic value of OnKure Therapeutics,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OnKure Therapeutics,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OnKure Therapeutics, helps investors to forecast how OnKure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OnKure Therapeutics, more accurately as focusing exclusively on OnKure Therapeutics,'s fundamentals will not take into account other important factors: OnKure Therapeutics, Company Current Valuation Analysis
OnKure Therapeutics,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
OnKure Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for OnKure Therapeutics, is extremely important. It helps to project a fair market value of OnKure Stock properly, considering its historical fundamentals such as Current Valuation. Since OnKure Therapeutics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OnKure Therapeutics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OnKure Therapeutics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, OnKure Therapeutics, has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
OnKure Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OnKure Therapeutics,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OnKure Therapeutics, could also be used in its relative valuation, which is a method of valuing OnKure Therapeutics, by comparing valuation metrics of similar companies.OnKure Therapeutics, is currently under evaluation in current valuation category among its peers.
OnKure Fundamentals
| Net Income | (35.31 M) | ||||
| Total Debt | 137.58 M | ||||
| Total Asset | 35.73 M | ||||
| Retained Earnings | (102.05 M) | ||||
| Working Capital | 26.48 M | ||||
| Net Asset | 35.73 M |
About OnKure Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OnKure Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OnKure Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OnKure Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with OnKure Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
| 0.76 | CEROW | CERo Therapeutics Symbol Change | PairCorr |
| 0.73 | ENZN | Enzon Pharmaceuticals | PairCorr |
| 0.73 | BAYRY | Bayer AG PK | PairCorr |
| 0.71 | FNCH | Finch Therapeutics | PairCorr |
| 0.48 | ENSCW | Ensysce Biosciences | PairCorr |
The ability to find closely correlated positions to OnKure Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics, to buy it.
The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.